Malignant Glioma — Trials

Malignant Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 589
Recruiting: 314
Ph III recruiting: 16
Growth YoY: +38.9%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (325)

clinicaltrialsPublishedShowing 1–50 of 253 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05685004	Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)	active not recruiting	Phase 2 / Phase 3	120	TVAX BiomedicalINDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT05864534	Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma	active not recruiting	Phase 2	25	Northwestern UniversityOTHER	1	Sep 29, 2026	clinicaltrials